Dynamically Programmable Magnetic Fields for Controlled Movement of Cells Loaded with Iron Oxide Nanoparticles
Abstract
Cell-based therapies are becoming increasingly prominent in numerous medical contexts, particularly in regenerative medicine and the treatment of cancer. However, since the efficacy of the therapy is largely dependent on the concentration of therapeutic cells at the treatment area, a major challenge associated with cell-based therapies is the ability to move and localize therapeutic cells within the body. In this article, a technique based on dynamically programmable magnetic fields is successfully demonstrated to noninvasively aggregate therapeutic cells at a desired location. Various types of therapeutically relevant cells (neural stem cells, monocytes/macrophages, and chimeric antigen receptor T cells) are loaded with iron oxide nanoparticles and then focused at a particular site using externally controlled electromagnets. These experimental results serve as a readily scalable prototype for designing an apparatus that patients can wear to focus therapeutic cells at the anatomical sites needed for treatment.
Additional Information
© 2020 American Chemical Society. Received: February 27, 2020; Accepted: May 28, 2020; Published: May 28, 2020. We gratefully acknowledge Marcia Miller, Zhuo Li, and Ricardo Zerda for electron microscopy performed in the EM core facility and Brian Armstrong, Loren Quintanar, and Tina Patel for their assistance with fluorescence imaging performed in the Light Microscopy and Digital Imaging Core. Research reported in this publication included work performed in the Electron Microscopy and the Light Microscopy and Digital Imaging Cores supported by the National Cancer Institute of the National Institutes of Health under award number P30CA033572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would like to thank R01CA155769, R21CA189223, R21 NS081594, NIH grant 51013.914960.6692, The Kenneth T. and Eileen L. Norris Foundation, and STOP Cancer for research funding. Author Contributions: B.B., A.H., and J.M.B. contributed equally to this work. The authors declare no competing financial interest.Attached Files
Supplemental Material - mt0c00226_si_004.pdf
Supplemental Material - mt0c00226_si_005.avi
Supplemental Material - mt0c00226_si_006.avi
Supplemental Material - mt0c00226_si_007.avi
Supplemental Material - mt0c00226_si_008.avi
Supplemental Material - mt0c00226_si_009.mov
Files
Name | Size | Download all |
---|---|---|
md5:cfb1e3bf290b6ba8776fa9c082ce25cf
|
37.1 MB | Download |
md5:eabd60fae8aff73f4f9a49cbdbba0741
|
195.0 MB | Download |
md5:e7d87e258c78adcbdb0956362387ceab
|
22.1 MB | Download |
md5:5bca0b4e4c434c4a2a3f5738f4b14004
|
5.6 MB | Preview Download |
md5:72ede2f8d660c104a76d201730c23a57
|
35.5 MB | Download |
md5:e0e26d38ec121223ea056b641c34892b
|
70.9 MB | Download |
Additional details
- Eprint ID
- 103517
- Resolver ID
- CaltechAUTHORS:20200528-104303291
- NIH
- P30CA033572
- NIH
- R01CA155769
- NIH
- R21CA189223
- NIH
- R21NS081594
- NIH
- 51013.914960.6692
- Kenneth T. and Eileen L. Norris Foundation
- STOP Cancer
- Created
-
2020-05-28Created from EPrint's datestamp field
- Updated
-
2021-11-16Created from EPrint's last_modified field